Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Pregnancy Management of a Woman With Severe Methylmalonic Acidemia.

JIMD reports·2025
Same author

Rare human skin infection with Corynebacterium ulcerans: transmission by a domestic cat.

Infection·2012
Same author

Febrile seizures in children during the Influenza A (H1N1) pandemic 2009/2010.

Klinische Padiatrie·2011
Same author

[A drug addict presenting with complicated tricuspid valve endocarditis].

Der Internist·2010
Same author

[Comment on rule of thumb 6 in Praxis no. 16. Cough and rhinitis: no Strep A angina].

Praxis·2009
Same author

[Comment on rule number 1 in Praxis no.1].

Praxis·2009

Related Experiment Video

Updated: Jul 4, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

[Influenza vaccination present and future].

G Eich1

  • 1Departement Innere Medizin, Infektiologie/Spitalhygiene, Stadtspital Triemli, Zürich. gerhard.eich@triemli.stzh.ch

Therapeutische Umschau. Revue Therapeutique
|June 28, 2008
PubMed
Summary

Influenza vaccination is highly effective in healthy adults but less so in the elderly. However, it significantly prevents severe complications like pneumonia and death in older individuals, especially those in nursing homes.

Area of Science:

  • Immunology
  • Virology
  • Public Health

Context:

  • Influenza vaccination effectiveness varies by age and health status, with reduced efficacy in individuals over 65 and those with comorbidities.
  • Despite lower efficacy in preventing infection, influenza vaccination remains crucial for preventing severe outcomes in the elderly, including pneumonia, hospitalization, and death.
  • Current recommendations target vaccination for individuals over 65, high-risk groups, healthcare workers, and those with occupational exposure to avian influenza.

Purpose:

  • To summarize the current understanding of influenza vaccine effectiveness, safety, and recommendations.
  • To highlight the benefits of influenza vaccination in preventing severe complications in the elderly and high-risk populations.
  • To address the limitations of current vaccine production timelines and the need for improved and universal influenza vaccines.

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Related Experiment Videos

Last Updated: Jul 4, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Summary:

  • Influenza vaccines are generally safe with rare severe complications, though effectiveness can be limited in older adults and those with underlying health conditions.
  • Vaccination is particularly beneficial for the elderly, reducing hospital admissions and deaths from influenza and associated pneumonia, with greater impact in institutionalized populations.
  • The annual strain selection and production process, taking up to six months, poses a challenge for rapid pandemic response, necessitating research into faster production methods and universal vaccines.

Impact:

  • Influenza vaccination plays a vital role in mitigating severe disease, hospitalization, and mortality associated with seasonal influenza, particularly in vulnerable populations.
  • The findings underscore the importance of continued vaccination efforts and public health strategies to protect against influenza-related morbidity and mortality.
  • Advancements in vaccine technology, including accelerated production and universal vaccine development, are critical for enhancing global preparedness against influenza pandemics.